An Evaluation Of The Chinese Pharmaceutical Market

Loading...
Thumbnail Image
Authors
Zhang, Mei
Issue Date
1991
Type
Thesis
Language
en_US
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Some of the major products produced in China include antibiotics, cancer medications, vitamins and cardiovascular drugs. However, due to the lack of domestic manufacturing or availability, several pharmaceuticals need to be imported. Furthermore, the Chinese market needs different types of product formulations. For example, doctors prefer an oral formulation as opposed to injectible. Both doctors and patients would benefit from the conveniences of an oral formulation. Additionally, pediatricians seek medications made specifically for children as opposed to the adult strength. In order to help develop health-care in China, the state has been required to promote the use of both western style and Traditional Chinese Medicine {TCM) since 1983. Foreign industries who invest into China's pharmaceutical market should study the country's goals, prospects, and priorities as part of their feasibility studies prior to investing. Joint ventures that meet the needs of China will have excellent prospects. In the long term, as joint venture enhance China's technology the PRC will further allow foreign companies to invest in and profit from needed development projects. Although, foreign joint ventures must recognize the impossibility of foreign ownership and control. As with other joint ventures, conducting business can pose various risks, but these risks can be overcome.
Description
xii, 92 p.
Citation
Publisher
License
U.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder.
Journal
Volume
Issue
PubMed ID
DOI
ISSN
EISSN